Öztürk, M.İ.; Ekici, M.; Aydın, C.; Çağlayan, M.S.; Doğan, M.; Baykam, M.M.
Preoperative Platelet-to-Lymphocyte Ratio as a Predictor of Recurrence and Recurrence-Free Survival in Non-Muscle-Invasive Bladder Cancer Across Different Intravesical Therapies. J. Clin. Med. 2026, 15, 5199.
https://doi.org/10.3390/jcm15135199
AMA Style
Öztürk Mİ, Ekici M, Aydın C, Çağlayan MS, Doğan M, Baykam MM.
Preoperative Platelet-to-Lymphocyte Ratio as a Predictor of Recurrence and Recurrence-Free Survival in Non-Muscle-Invasive Bladder Cancer Across Different Intravesical Therapies. Journal of Clinical Medicine. 2026; 15(13):5199.
https://doi.org/10.3390/jcm15135199
Chicago/Turabian Style
Öztürk, Muhammet İhsan, Musa Ekici, Cemil Aydın, Mustafa Serdar Çağlayan, Mücahit Doğan, and Mehmet Murat Baykam.
2026. "Preoperative Platelet-to-Lymphocyte Ratio as a Predictor of Recurrence and Recurrence-Free Survival in Non-Muscle-Invasive Bladder Cancer Across Different Intravesical Therapies" Journal of Clinical Medicine 15, no. 13: 5199.
https://doi.org/10.3390/jcm15135199
APA Style
Öztürk, M. İ., Ekici, M., Aydın, C., Çağlayan, M. S., Doğan, M., & Baykam, M. M.
(2026). Preoperative Platelet-to-Lymphocyte Ratio as a Predictor of Recurrence and Recurrence-Free Survival in Non-Muscle-Invasive Bladder Cancer Across Different Intravesical Therapies. Journal of Clinical Medicine, 15(13), 5199.
https://doi.org/10.3390/jcm15135199
